Corporate Compliance

Other CMS and OIG Issuances

Medicare Weekly Update, April 29, 2008

Want to receive articles like this one in your inbox? Subscribe to Medicare Weekly Update!

CMS issues national coverage decision (NCD) on blood-derived products for treatment of chronic non-healing wounds

On April 22, CMS issued an NCD announcing that the following blood-derived products for the treatment of chronic non-healing wounds will continue to be noncovered:

  • Autologous platelet derived growth factor for the treatment of chronic non-healing cutaneous wounds
  • Autologous platelet rich plasma for the treatment of chronic non-healing cutaneous wounds
  • Treatments using becaplermin, a non-autologous growth factor for chronic non-healing wounds

View the NCD.



Want to receive articles like this one in your inbox? Subscribe to Medicare Weekly Update!

Comments

0 comments on “Other CMS and OIG Issuances

 

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

  • Medicare Update for Physician Services

    Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...

Most Popular

Related Articles